Articles with public access mandates - Erik RobersonLearn more
OverallNIHCIHRDoDMRCWellcomeHHMIVANSFCSwedish Research CouncilAlzheimers's UKNIHRGovernment of SpainNSFNWOEuropean CommissionZonMwGovernment of ItalyFWODFGAcademy of FinlandINSERMParkinson's UKBMBFMichael J Fox FoundationParkinson's Foundation, USAMarianne and Marcus Wallenberg FoundationDMTMotor Neurone Disease Association, UKState of CalifoniaAXA Research Fund, FranceBrain Research, UKSNSFAHAFWFARCNHMRCNSERCHelmholtzBanking Foundation "la Caixa"Knut and Alice Wallenberg FoundationANRPCORINMRCJDRFFlorida Department of Health, USABELSPOCZI
Not available anywhere: 3
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders
A Gerstenecker, L Grimsley, B Otruba, L Cowden, DC Marson, ...
Parkinsonism & related disorders 61, 77-81, 2019
Mandates: US National Institutes of Health
Contemporary approaches to Alzheimer’s disease and frontotemporal dementia
ED Roberson
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols, 1-9, 2011
Mandates: US National Institutes of Health
Molecular and structural insight into the differences among common and rare Alzheimer's disease-associated apoE variants
RA Greer, RA Tuckey, HB Dean, ED Roberson, Y Song
Biophysical Journal 122 (3), 333a, 2023
Mandates: US National Institutes of Health
Available somewhere: 132
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Mandates: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Amyloid-β/Fyn–induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease
ED Roberson, B Halabisky, JW Yoo, J Yao, J Chin, F Yan, T Wu, P Hamto, ...
Journal of Neuroscience 31 (2), 700-711, 2011
Mandates: US National Institutes of Health
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes
G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ...
Archives of neurology 67 (12), 1473-1484, 2010
Mandates: US National Institutes of Health
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
KA Vossel, KG Ranasinghe, AJ Beagle, D Mizuiri, SM Honma, ...
Annals of neurology 80 (6), 858-870, 2016
Mandates: US National Science Foundation, US National Institutes of Health
Mouse models of Alzheimer's disease
AM Hall, ED Roberson
Brain research bulletin 88 (1), 3-12, 2012
Mandates: US National Institutes of Health
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
DC Whitcomb, J LaRusch, AM Krasinskas, L Klei, JP Smith, RE Brand, ...
Nature genetics 44 (12), 1349-1354, 2012
Mandates: US National Institutes of Health, German Research Foundation
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
Mandates: US National Institutes of Health, Australian Research Council, National …
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
H Qiu, S Lee, Y Shang, WY Wang, KF Au, S Kamiya, SJ Barmada, ...
The Journal of clinical investigation 124 (3), 981-999, 2014
Mandates: US National Institutes of Health
A novel Alzheimer disease locus located near the gene encoding tau protein
G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ...
Molecular psychiatry 21 (1), 108-117, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs, Howard …
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
TW Schmitz, R Nathan Spreng
Nature communications 7 (1), 13249, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Assessment of the genetic variance of late-onset Alzheimer's disease
PG Ridge, KB Hoyt, K Boehme, S Mukherjee, PK Crane, JL Haines, ...
Neurobiology of aging 41, 200. e13-200. e20, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs, UK …
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ...
Nature medicine 27 (7), 1187-1196, 2021
Mandates: US National Institutes of Health, Federal Ministry of Education and Research …
Publication and funding information is determined automatically by a computer program